A Phase 2 double-blind randomized placebo-controlled crossover study evaluating the effect of RVT-101 on gait and balance in subjects with Alzheimer's Disease Dementia with Lewy Bodies or Parkinson's Disease Dementia
J
Jared Brosch, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Not Recruiting
50 years - 89 years
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to investigate whether RVT-101 can improve gait and balance in subjects with Alzheimer?s disease, dementia with Lewy bodies, or Parkinson?s disease dementia who suffer from problems related to balance, walking, and falls.
Detailed description of study
The purpose of this study is to investigate whether RVT-101 can improve gait and balance in subjects with Alzheimer's disease, dementia with Lewy bodies, or Parkinson's disease dementia who suffer from problems related to balance, walking and falls.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Alzheimer's disease,dementia with Lewy bodies
-
Age: 50 years - 89 years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1611337897
